Detalhe da pesquisa
1.
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.
Breast Cancer Res Treat
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709373
2.
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Breast Cancer Res Treat
; 190(2): 295-305, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524591
3.
Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.
J Pathol
; 250(3): 262-274, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755096
4.
Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.
Br J Cancer
; 120(2): 247-255, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563991
5.
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Breast Cancer Res Treat
; 176(2): 377-386, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31041683
6.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
; 20(1): 103, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180877
7.
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
Breast Cancer Res
; 19(1): 113, 2017 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029636
8.
Therapy-induced normal tissue damage promotes breast cancer metastasis.
iScience
; 27(1): 108503, 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161426
9.
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.
Eur J Cancer
; 164: 52-61, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172273
10.
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.
Clin Cancer Res
; 28(20): 4494-4508, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161312
11.
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
J Clin Oncol
; 39(2): 126-135, 2021 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108242
12.
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
NPJ Breast Cancer
; 7(1): 15, 2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579961
13.
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors.
Cell Rep Med
; 2(12): 100457, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028604
14.
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma.
Cancers (Basel)
; 13(15)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359755
15.
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.
Cancer Res
; 81(4): 847-859, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509944
16.
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.
Clin Cancer Res
; 26(17): 4682-4687, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561662
17.
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
Clin Cancer Res
; 26(3): 623-631, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31641007
18.
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759235
19.
Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914010
20.
Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors.
Clin Cancer Res
; 25(24): 7485-7496, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548345